Vulnerable Populations in Clinical Research
GCP requirements and ethical considerations for including vulnerable populations in clinical research.
PharmacologyALCOA and ALCOA+ Principles
An overview of the ALCOA and ALCOA+ principles that define data quality attributes for regulated GxP environments.
PharmacologyArchiving and Retrieval
Archiving and retrieval practices for GxP records in pharmaceutical manufacturing and laboratory environments.
PharmacologyAudit Trails
Understanding audit trail requirements for electronic GxP systems and their role in maintaining data integrity.
PharmacologyBatch Record Recordkeeping
Best practices for batch record recordkeeping in pharmaceutical manufacturing to ensure data integrity and compliance.
PharmacologyCorrection and Revision Practices
Proper procedures for correcting and revising GxP documents to maintain data integrity and audit readiness.
PharmacologyData Integrity Fundamentals
Fundamental concepts of data integrity in pharmaceutical manufacturing and how it relates to ALCOA+ principles and GDP.
PharmacologyData Integrity Risk Assessment
Conducting data integrity risk assessments for GxP systems to identify and mitigate documentation risks.
PharmacologyDocument Numbering and Version Control
Systems for document numbering and version control in pharmaceutical GxP environments to ensure traceability.
PharmacologyElectronic Records and 21 CFR Part 11
Understanding 21 CFR Part 11 requirements for electronic records and signatures in FDA-regulated pharmaceutical environments.
PharmacologyEU Annex 11 Compliance
Requirements for EU Annex 11 compliance covering computerized systems in the pharmaceutical manufacturing environment.
PharmacologyHybrid Systems (Paper and Electronic)
Managing hybrid systems that combine paper and electronic records in pharmaceutical GxP environments.
Pharmacology